newsfilter
← Latest News
Business Wire·

Biocept Announces a Delay in the Filing of its Quarterly Report on Form 10-Q

Biocept, Inc. (NASDAQ:BIOC), a leading provider of molecular diagnostic assays, products, and services, announces a delay in the filing of its Quarterly Report on Form 10-Q for the quarter ended June 30, 2022. The delay is related to the ongoing account